Driving innovation: India's foray into gene and cell therapies

Quick Summary:

India is progressing in cell and gene therapy.

Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.

The Indian pharma industry has already built bio-manufacturing infrastructure primarily focused on chemical entities, and this is now starting to be adapted for biological entities.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: ET CONTRIBUTORS

Category: Business

Markets: IndiaAzerbaijanCubaGermanyUnited States

Topics: CRISPR-Cas therapies Gene Therapies in India Gene therapy Haemophilia A treatment Cell Therapies

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-27 @ 11:04:50 (1 days ago)

News Timezone: GMT +8:00

News Source URL: economictimes.indiatimes.com

Language: English

Article Length: 1395 words

Reading Time: 8 minutes read

Sentences: 47 lines

Sentence Length: 30 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Economic Times

News ID: 24687350

View Article Analysis

About Economic Times

Main Topics: Business

Official Website: economictimes.indiatimes.com

Update Frequency: 5 posts per day

Year Established: 1961

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #84

Publisher Details

Frequently Asked Questions